Kadakia Sameep, Saman Masoud, Gordin Eli, Marra Diego, Ducic Yadranko
Department of Otolaryngology-Head and Neck Surgery, The New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA.
Department of Facial Plastic and Reconstructive Surgery, Otolaryngology and Facial Plastic Surgery Associates, Fort Worth, Texas, USA.
Otolaryngol Head Neck Surg. 2015 Jun;152(6):1048-52. doi: 10.1177/0194599815579885. Epub 2015 Apr 8.
We analyze parotid specimens in patients treated with prophylactic parotidectomy for squamous cell carcinoma of the auricle greater than or equal to 2 cm to determine rates of metastasis and the efficacy of elective resection.
Case series with chart review.
Cancer treatment center in Fort Worth, Texas, from 1998 to 2013.
The study included 104 patients between ages 36 and 97 years with primary auricular squamous cell carcinoma greater than or equal to 2 cm, with no evidence of adenopathy or parotid involvement on imaging. Patients underwent local excision and ipsilateral parotidectomy. The primary cancer was analyzed for vascular involvement, perineural invasion, and cartilage involvement, while the parotid specimen was analyzed for cancer positivity.
Thirty-nine parotid (37.5%) samples were positive for carcinoma. Of these, 16 patients had primary auricular carcinomas with vascular involvement, 17 had perineural invasion, and 4 had cartilage involvement. Thirty-two of 77 affected men and 7 of 27 affected women had positive parotid specimen. Vascular involvement (P = .0006) and perineural invasion (P = .0027) of the primary lesion were significantly higher in patients with a positive parotid specimen. Cartilage involvement and sex were not statistically significant.
Elective parotidectomy is beneficial in patients with squamous cell carcinoma of the auricle at least 2 cm in size, especially in lesions having perineural invasion and vascular involvement. For patients with positive parotid specimens, we recommend postoperative external beam radiation therapy and close surveillance.
我们分析了因耳廓鳞状细胞癌(肿瘤大小大于或等于2厘米)而接受预防性腮腺切除术患者的腮腺标本,以确定转移率和选择性切除的疗效。
病例系列研究并进行病历回顾。
德克萨斯州沃思堡的癌症治疗中心,时间跨度为1998年至2013年。
该研究纳入了104名年龄在36至97岁之间的患者,这些患者患有原发性耳廓鳞状细胞癌,肿瘤大小大于或等于2厘米,影像学检查未发现淋巴结病或腮腺受累迹象。患者接受了局部切除和同侧腮腺切除术。对原发性癌症进行血管侵犯、神经周围侵犯和软骨侵犯分析,同时对腮腺标本进行癌症阳性分析。
39份腮腺样本(37.5%)癌症呈阳性。其中,16例原发性耳廓癌患者有血管侵犯,17例有神经周围侵犯,4例有软骨侵犯。77名患病男性中有32名、27名患病女性中有7名腮腺标本呈阳性。腮腺标本阳性的患者,其原发性病变的血管侵犯(P = 0.0006)和神经周围侵犯(P = 0.0027)明显更高。软骨侵犯和性别无统计学意义。
对于至少2厘米大小的耳廓鳞状细胞癌患者,选择性腮腺切除术有益,尤其是对于有神经周围侵犯和血管侵犯的病变。对于腮腺标本呈阳性的患者,我们建议术后进行外照射放疗并密切监测。